Specific and sensitive amplification of major outer membrane protein (MOMP) DNA sequences corresponding to the ompA restriction fragment length polymorphism type B577 of C. psittaci were detected in two of seven milk samples from cases of bovine mastitis.
mydiae were analyzed (12) . Four groups of MOMP genotypes were found. C. trachomatis with the porcine chlamydial isolate S45 made up the trachoma group. C. pneumoniae combined with the MOMP genotype KOALA of isolates from the koala (Phascolarctos cinereus) formed the pneumonia group. A cluster of C. psittaci strains from ruminant and porcine hosts with a propensity for causing polyarthritispolyserositis was termed the polyarthritis group. Strains of C. psittaci originating from avian, human, ruminant, feline, and guinea pig hosts made up the psittacosis group.
On the basis of these findings, we explored the possibility of sensitive genus-specific detection of Chlamydia spp. by PCR. We report here the detection of Chlamydia spp. by PCR amplification of MOMP gene DNA sequences, the PCR-based classification of chlamydial MOMP genes into four major groups, the differentiation of ompA restriction fragment length polymorphism (RFLP) types within these groups by restriction endonuclease analysis, and the detection of C. psittaci in clinical specimens.
(This report contains parts of a dissertation presented by B. Kaltenboeck to the Graduate School of Louisiana State University in partial fulfillment of the requirements for the Ph.D. degree.)
MATERIALS AND METHODS
Chlamydial strains. Thirteen strains of Chlamydia representing 13 MOMP genotypes; at least nine serovars; and six genomic RFLP types of human, koala, bovine, ovine, porcine, feline, guinea pig, and murine origin (7, 12, 20) were used in this investigation. Relevant information about the isolates is summarized in Table 1 . All chlamydial strains MOMP genotypes were determined by Kaltenboeck et al. (12) . Serovars of C. psittaci were determined by Perez-Martinez and Storz (20) ; the serovar of C. trachomatis L2 was determined by Wang and Grayston (26) . 'RFLP types were determined by Fukushi and Hirai (7). except C. pneumoniae AR388 and C. psittaci KOALA were propagated in developing chicken embryos as described previously (20) . In addition, strain B577 was also cultivated in persistently infected L cells (21) .
Extraction of chlamydial DNA. Heavily infected yolk sacs and purified B577 elementary bodies were used for the isolation of chlamydial DNA by cetyltrimethylammonium bromide extraction as described previously (13) . Purified DNAs from C. pneumoniae AR388 and C. psittaci KOALA were kind gifts of L. A. Campbell, University of Washington, Seattle, and Adeeb A. Girjes, University of Queensland, Brisbane, Queensland, Australia, respectively.
Chlamydia-negative background DNAs from uninfected L cells and bacteria likely to be encountered in clinical specimens (Eschenichia coli, Salmonella cholerae-suis, Bordetella bronchiseptica, Pseudomonas aeruginosa) were extracted after low-speed sedimentation as described previously (13) .
Oligonucleotide primers. A schematic representation of the chlamydial MOMP gene (now termed ompA [27] ), the relative locations of the primers, and the DNA fragments generated in the PCRs are presented in Fig. 1 . The primers are described in Table 2 . These degenerate, inosine-containing oligonucleotide primers (17) genus-specific primer 29CHOMP, they generated DNA fragments of different lengths characteristic of their respective chlamydial ompA target (Fig. 1) .
PCR amplification. All PCRs were performed with 2. were used at 0.2 p.M each in Chlamydia genus-specific primary amplification; primers 29CHOMP and CHOMP336 were used in genus-specific secondary amplification. Primers TROMP358, PNOMP268, and PSOMP204 were used together with 29CHOMP at 0.1 p.M each in the secondary groupspecific amplification. To avoid PCR product carryover, positive displacement pipettes were used, and DNA was extracted and PCRs were assembled in two different laboratories, which were strictly kept free of amplification products. The samples were overlaid with mineral oil; and in the primary amplification, they were subjected to 40 (12) . The MOMP genotypes of these chlamydial groups were differentiated as ompA RFLP types with the following restriction endonucleases: psittacosis with HaeIII, trachoma with PvuII, pneumonia with Fnu4HI, and polyarthritis with BstUI and BstYI. Ten to 20 p.1 of the secondary PCRs was mixed with the appropriate buffer and restricted for 1 h at the recommended temperature by using 10 U of the respective enzymes (New England Biolabs, Beverly, Mass.). The specificity of the amplification was confirmed through (i) the appearance of a single DNA fragment of the expected size and (ii) the appearance of restriction patterns of the amplified secondary DNA fragments as expected from the DNA sequences of the partial MOMP genes.
Clinical samples. Seven milk samples were obtained from cows suffering from chronic mastitis of variable severities.
These cows were randomly selected from different herds surveyed in a mastitis control program. Low numbers of E.
coli were found in sample 2200 LR by standard bacteriological techniques; all other samples were free of detectable bacteria. DNA was extracted as described earlier (13) .
Samples of 10 p.l of DNA (0.2 to 0.7 pug) were subjected to primary amplification, and subsequent procedures were performed as described above.
RESULTS
Determination of the sensitivity of genus-specific PCR amplification. The efficiency of PCR amplification was optimized in a series of experiments (11) . Subsequently, the sensitivities of primary and combined primary and secondary genus-specific amplifications were determined. The Genus-specific PCR amplification of chlamydial MOMP gene fragments. To verify the spectrum of MOMP genes of Chlamydia that can be amplified, we isolated DNA from yolk sacs infected with strains with representative chlamydial MOMP genotypes. Diluted samples (1:100) were subjected to primary and secondary amplifications. The results indicated that all chlamydial MOMP genes were amplified by the genus-specific oligonucleotide primers (Fig. 3A and B) . Specific amplification of the chlamydial target DNA was indicated by the presence of a single specific DNA fragment in electrophoretic analysis of primary and secondary genusspecific PCRs. The slightly different migrations of DNA fragments indicated size differences in the MOMP genes.
Thus, the two-step PCR of the chlamydial MOMP gene with the primers 9CHOMP, CHOMP371, 29CHOMP, and CHOMP336 amplifies DNA fragments from the known chlamydiae and might also detect as yet undefined chlamydial variants.
Differentiation of groups of chlamydial MOMP genotypes by PCR amplification. The secondary group-specific PCR was developed as a tool for rapid preliminary classification of chlamydial MOMP genotypes. The antisense, groupspecific primers TROMP358, PNOMP268, and PSOMP204 were designed to hybridize under stringent conditions with different fingerprint regions of the MOMP genes of their respective cognate groups but not with chlamydial MOMP genes of the other groups. This resulted in a multiplex PCR (4) in which the genus-specific sense primer 29CHOMP was shared by all amplified DNA fragments (see Fig. 3C and 5C) fragments of the expected lengths ( Table 3 ). As anticipated, MOMP genes of strains FEPN, GPIC, B577, and BMZ1121 of the psittacosis group could not be amplified. This group was identified through positive amplification only in the secondary genus-specific PCR.
The positive control sample (see left lane of Fig. 5C ) was the secondary group-specific amplification of a sample from a primary PCR containing DNA of chlamydial MOMP genotypes represented by strains L2, AR388, and LW613. The simultaneous appearance of DNA fragments specific for the chlamydial groups trachoma, pneumonia, and polyarthritis confirmed the potential of the secondary group-specific amplification to identify multiple infections with certain chlamydial MOMP genotypes.
Thus, in combination with genus-specific PCRs, the secondary group-specific amplification differentiated between four groups of chlamydial MOMP genotypes. Furthermore, it identified the simultaneous presence of chlamydial strains of the trachoma, pneumonia, and polyarthritis groups.
Differentiation of chlamydial MOMP genotypes by restriction endonuclease analysis of amplified DNA fragments.
Knowledge of the partial MOMP gene DNA sequences of the chlamydial MOMP genotypes listed in Tables 1 and 3 20 ± l 1 of amplified secondary PCRs (genus specific for the psittacosis group; group specific for the trachoma, pneumonia, and polyarthritis groups) was mixed with restriction buffer and incubated with 10 U of the indicated restriction endonucleases. DNA fragments were resolved by 4% agarose gel electrophoresis (1:3 ratio of DNA-grade agarose to NuSieve agarose) and ethidium bromide staining.
(apparent mobility, approximately 360 bp) and, most notably, the 576-bp fragment of strain AR388, which migrated with an apparent mobility of approximately 620 bp. These aberrant mobilities were consistently found in analyses with different agarose concentrations and electrophoresis buffers. However, the original secondary DNA fragments of the MOMP genes of the different genotypes represented by these strains had the correct lengths ( Fig. 3B and C) , and after restriction the remaining fragments of the original amplified DNAs were identified at the correct positions. These results indicate that restriction endonuclease analysis of secondary MOMP gene amplification products can unambiguously achieve the intended differentiation of chlamydial ompA RFLP types. PCR analysis of clinical samples. We analyzed the milk of seven dairy cows suffering from mastitis to assess the applicability of the established PCR amplification for detection of chlamydial MOMP gene sequences in clinical samples. Specific DNA fragments could not be visualized in the primary amplification, indicating that there were a low number of chlamydiae in the samples (Fig. 5) 27 secondary PCR cycles, resulting in a sensitivity limit of three chlamydial templates, because, occasionally, the negative control reactions became weakly positive when additional cycles of secondary amplification were used. Thus, the two-step PCR amplification procedure offers the advantage that the sensitivity of the system can easily be adjusted.
The absolute detection limit of this method is given by the ratio of chlamydial target DNA to background DNA. The minimal ratio is one target molecule per approximately 1 ,ug of DNA in a 100-,ul PCR. At background DNA levels above 1 ,ug.per 100-,ul PCR, unspecific amplification dramatically increases while the efficiency of the specific amplification is reduced. Consequently, the sensitivity of chlamydial detection can be further improved only by minimizing the amount of background DNA. This can be achieved by differential sedimentation of cellular nuclei after sonication of a sample.
Assuming a Poisson distribution in DNA samples, falsenegative results are predicted to appear with low amounts of chlamydial DNA. Analysis of multiple samples are necessary to confirm truly negative reactions.
An important advantage of the two-step PCR detection procedure with two nested pairs of unrelated primers is its high specificity (16) . This method requires only minimal laboratory equipment for amplification and detection of the amplified DNA fragments. It can be performed in 1 workday without additional detection techniques, such as Southern hybridization or enzyme-linked immunosorbent assay-based hybrid capture assays (2) .
We designed the genus-specific primers 9CHOMP, CHOMP371, 29CHOMP, and CHOMP336 from highly conserved DNA sequences of the 5' and 3' ends of the translated ompA regions for recognition of the broadest possible spectrum of chlamydial MOMP genes. The chlamydial strains analyzed in this investigation constitute a comprehensive set of chlamydial variants. These primers matched the DNA sequences of genes of MOMP genotypes not examined in this study (those of strains 6BC, OA, LW508) and some serovars of C. trachomatis except L2. The complete MOMP gene DNA sequences of C. trachomatis serovars Ba, D, G, I, J, K, and L3 have not been determined. The cognate regions of the primers at the 5' and 3' ends of the MOMP gene are the most highly conserved ompA sequences. It is expected that these primers will hybridize and amplify these genes.
The secondary group-specific amplification facilitated rapid identification of the overall position within the chlamydial phylogeny of an amplified MOMP gene DNA fragment. It was also capable of detecting mixed infections with chlamydial strains of the trachoma, pneumonia, and polyarthritis groups. The sensitivity of this amplification varied slightly, depending on the length of the amplified groupspecific DNA fragment, but it could be adjusted like the secondary genus-specific amplification could.
Further differentiation of amplified products can be achieved by RFLP analysis. The availability of MOMP gene DNA sequences allows an appropriate selection of restriction endonucleases for RFLP analysis.
While the RFLP analysis of the psittacosis, polyarthritis, and pneumonia groups differentiated a spectrum of MOMP genotypes, the analysis of the trachoma group was not comprehensive. The 
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The data presented in this report indicate that the MOMP gene of extant variants of the genus Chlamydia can be detected by a two-step PCR. Amplified DNA fragments can be easily differentiated by group-specific secondary amplification and RFLP analysis. This differentiation combined with rapid DNA sequencing of secondary genus-specific amplification products (12, 15) could lead to the identification of as yet undefined chlamydial variants. Unlike chlamydial infections in humans, the diseases caused by chlamydiae in animals are not widely recognized. We anticipate that PCR-based genus-specific detection and differentiation of Chlamydia spp. will contribute to understanding of the epidemiology and pathogenesis of chlamydial infections.
